Qualitative behavior of systems of tumor–CD4+–cytokine interactions with treatments
暂无分享,去创建一个
Jui-Ling Yu | Sophia R.-J. Jang | L. Anderson | S. Jang | Luke R. Anderson | Luke Anderson | Jui‐Ling Yu
[1] A. Perelson,et al. Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. , 1994, Bulletin of mathematical biology.
[2] M. Raffeld,et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.
[3] D. Kirschner,et al. Modeling immunotherapy of the tumor – immune interaction , 1998, Journal of mathematical biology.
[4] B. Quesnel. Dormant tumor cells as a therapeutic target? , 2008, Cancer letters.
[5] P. Foster,et al. Immunotherapy of Cytotoxic T Cell–resistant Tumors by T Helper 2 Cells , 2003, The Journal of experimental medicine.
[6] D. Earn,et al. Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models , 2011, Bulletin of mathematical biology.
[7] F. A. Goswitz,et al. Spontaneous cyclic leukocytosis and thrombocytosis in chronic granulocytic leukemia. , 1972, The New England journal of medicine.
[8] S. Rosenberg,et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. , 1988, The New England journal of medicine.
[9] Yuri Kogan,et al. Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics , 2008, Cancer Immunology, Immunotherapy.
[10] J. Leith,et al. Tumor micro-ecology and competitive interactions. , 1987, Journal of theoretical biology.
[11] M. Kaplan,et al. CD4+ T‐cell‐mediated anti‐tumor immunity can be uncoupled from autoimmunity via the STAT4/STAT6 signaling axis , 2009, European journal of immunology.
[12] L. D. Pillis,et al. A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor Growth , 2005 .
[13] T. Olencki,et al. T-cell adoptive immunotherapy of metastatic renal cell carcinoma. , 1999, Urology.
[14] Urszula Foryś,et al. ANTI-TUMOR IMMUNITY AND TUMOR ANTI-IMMUNITY IN A MATHEMATICAL MODEL OF TUMOR IMMUNOTHERAPY , 2006 .
[15] Olivier Lantz,et al. CD4 cells can be more efficient at tumor rejection than CD8 cells. , 2007 .
[16] D. Earn,et al. Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma. , 2010, Journal of theoretical biology.
[17] W. S. Hlavacek,et al. Mathematical and computational models of immune-receptor signalling , 2004, Nature Reviews Immunology.
[18] B C Mehta,et al. Cyclic oscillations in leukocyte count in chronic myeloid leukemia. , 1980, Acta haematologica.
[19] H. P. de Vladar,et al. Dynamic response of cancer under the influence of immunological activity and therapy. , 2004, Journal of theoretical biology.
[20] J. Thompson,et al. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[21] S. Plesničar,et al. Actual doubling time values of pulmonary metastases from malignant melanoma. , 1978, The Australian and New Zealand journal of surgery.
[22] B. Kennedy,et al. Cyclic leukocyte oscillations in chronic myelogenous leukemia during hydroxyurea therapy. , 1970, Blood.